121 related articles for article (PubMed ID: 26808689)
1. mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia.
Engel M; Snikeris P; Matosin N; Newell KA; Huang XF; Frank E
Psychopharmacology (Berl); 2016 Apr; 233(8):1349-59. PubMed ID: 26861891
[TBL] [Abstract][Full Text] [Related]
2. Metabotropic Glutamate 2/3 Receptors and Epigenetic Modifications in Psychotic Disorders: A Review.
Matrisciano F; Panaccione I; Grayson DR; Nicoletti F; Guidotti A
Curr Neuropharmacol; 2016; 14(1):41-7. PubMed ID: 26813121
[TBL] [Abstract][Full Text] [Related]
3. AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study.
Litman RE; Smith MA; Doherty JJ; Cross A; Raines S; Gertsik L; Zukin SR
Schizophr Res; 2016 Apr; 172(1-3):152-7. PubMed ID: 26922656
[TBL] [Abstract][Full Text] [Related]
4. Brain PET measurement of PDE10A occupancy by TAK-063, a new PDE10A inhibitor, using [11 C]T-773 in nonhuman primates.
Takano A; Stepanov V; Nakao R; Amini N; Gulyás B; Kimura H; Halldin C
Synapse; 2016 Jun; 70(6):253-63. PubMed ID: 26878349
[TBL] [Abstract][Full Text] [Related]
5. TAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple Paradigms.
Suzuki K; Harada A; Suzuki H; Miyamoto M; Kimura H
Neuropsychopharmacology; 2016 Aug; 41(9):2252-62. PubMed ID: 26849714
[TBL] [Abstract][Full Text] [Related]
6. Maternal immune activation leads to selective functional deficits in offspring parvalbumin interneurons.
Canetta S; Bolkan S; Padilla-Coreano N; Song LJ; Sahn R; Harrison NL; Gordon JA; Brown A; Kellendonk C
Mol Psychiatry; 2016 Jul; 21(7):956-68. PubMed ID: 26830140
[TBL] [Abstract][Full Text] [Related]
7. Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosis.
Layton ME; Reif AJ; Hartingh TJ; Rodzinak K; Dudkin V; Wang C; Arrington K; Kelly MJ; Garbaccio RM; O'Brien JA; Magliaro BC; Uslaner JM; Huszar SL; Fillgrove KL; Tang C; Kuo Y; Jacobson MA
Bioorg Med Chem Lett; 2016 Feb; 26(4):1260-4. PubMed ID: 26810316
[TBL] [Abstract][Full Text] [Related]
8. Effects of the mGlu2/3 receptor agonist LY379268 on two models of disturbed auditory evoked brain oscillations in mice.
Dormann OD; Schuelert N; Rosenbrock H
Transl Psychiatry; 2023 May; 13(1):150. PubMed ID: 37147311
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotics-Induced Changes in Synaptic Architecture and Functional Connectivity: Translational Implications for Treatment Response and Resistance.
de Bartolomeis A; De Simone G; Ciccarelli M; Castiello A; Mazza B; Vellucci L; Barone A
Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551939
[TBL] [Abstract][Full Text] [Related]
10. Auditory EEG Biomarkers in Fragile X Syndrome: Clinical Relevance.
Ethridge LE; De Stefano LA; Schmitt LM; Woodruff NE; Brown KL; Tran M; Wang J; Pedapati EV; Erickson CA; Sweeney JA
Front Integr Neurosci; 2019; 13():60. PubMed ID: 31649514
[TBL] [Abstract][Full Text] [Related]
11. Acute administration of roflumilast enhances sensory gating in healthy young humans in a randomized trial.
Heckman PRA; Van Duinen MA; Blokland A; Uz T; Prickaerts J; Sambeth A
Psychopharmacology (Berl); 2018 Jan; 235(1):301-308. PubMed ID: 29098341
[TBL] [Abstract][Full Text] [Related]
12. Ketamine: differential neurophysiological dynamics in functional networks in the rat brain.
Ahnaou A; Huysmans H; Biermans R; Manyakov NV; Drinkenburg WHIM
Transl Psychiatry; 2017 Sep; 7(9):e1237. PubMed ID: 28926001
[TBL] [Abstract][Full Text] [Related]
13. Neural synchronization deficits linked to cortical hyper-excitability and auditory hypersensitivity in fragile X syndrome.
Ethridge LE; White SP; Mosconi MW; Wang J; Pedapati EV; Erickson CA; Byerly MJ; Sweeney JA
Mol Autism; 2017; 8():22. PubMed ID: 28596820
[TBL] [Abstract][Full Text] [Related]
14. The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia.
Griebel G; Pichat P; Boulay D; Naimoli V; Potestio L; Featherstone R; Sahni S; Defex H; Desvignes C; Slowinski F; Vigé X; Bergis OE; Sher R; Kosley R; Kongsamut S; Black MD; Varty GB
Sci Rep; 2016 Oct; 6():35320. PubMed ID: 27734956
[TBL] [Abstract][Full Text] [Related]
15. Modulation of mGlu2 Receptors, but Not PDE10A Inhibition Normalizes Pharmacologically-Induced Deviance in Auditory Evoked Potentials and Oscillations in Conscious Rats.
Ahnaou A; Biermans R; Drinkenburg WH
PLoS One; 2016; 11(1):e0147365. PubMed ID: 26808689
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4-amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039).
Fell MJ; Svensson KA; Johnson BG; Schoepp DD
J Pharmacol Exp Ther; 2008 Jul; 326(1):209-17. PubMed ID: 18424625
[TBL] [Abstract][Full Text] [Related]
17. Cortical high gamma network oscillations and connectivity: a translational index for antipsychotics to normalize aberrant neurophysiological activity.
Ahnaou A; Huysmans H; Van de Casteele T; Drinkenburg WHIM
Transl Psychiatry; 2017 Dec; 7(12):1285. PubMed ID: 29249806
[TBL] [Abstract][Full Text] [Related]
18. The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats.
Cartmell J; Monn JA; Schoepp DD
J Pharmacol Exp Ther; 1999 Oct; 291(1):161-70. PubMed ID: 10490900
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
